upper airway obstruction
Recently Published Documents


TOTAL DOCUMENTS

1412
(FIVE YEARS 160)

H-INDEX

54
(FIVE YEARS 2)

2022 ◽  
pp. 29-34
Author(s):  
Gareth Waters ◽  
Andrew Nyman

2021 ◽  
pp. 105566562110597
Author(s):  
Si Ling Pang ◽  
Cheuk Hin Angus Ho ◽  
Chun Man Lorie Law ◽  
Yanqi Yang ◽  
Yiu Yan Leung

Femoral facial syndrome (FFS) is a rare condition which may present with hypoplasia or aplasia of the femora and unusual facies characterized by long philtrum, thin upper lip and micrognathia. We present the case of a ten-month old infant with FFS who had retroglossal obstruction and who was treated with a pre-epiglottic baton plate. The pre-epiglottic baton plate can be a simple, non-invasive and effective tool for the clinical management of syndromic patients with mild-to-moderate upper airway obstruction due to micrognathia.


2021 ◽  
Vol 38 (11) ◽  
pp. 1196-1198
Author(s):  
Preethy J. Mathew ◽  
Ratnakumar Banoth ◽  
Vighnesh Ashok ◽  
Neerja Bhardwaj ◽  
Sandhya Yaddanapudi ◽  
...  

Children ◽  
2021 ◽  
Vol 8 (11) ◽  
pp. 979
Author(s):  
Kelly K. Hady ◽  
Caroline U. A. Okorie

Pediatric obstructive sleep apnea syndrome (OSAS) is a disorder of breathing during sleep, characterized by intermittent or prolonged upper airway obstruction that can disrupt normal ventilation and/or sleep patterns. It can affect an estimated 2–4% of children worldwide. Untreated OSAS can have far reaching consequences on a child’s health, including low mood and concentration as well as metabolic derangements and pulmonary vascular disease. Most children are treated with surgical intervention (e.g., first-line therapy, adenotonsillectomy); however, for those for whom surgery is not indicated or desired, or for those with postoperative residual OSAS, positive airway pressure (PAP) therapy is often employed. PAP therapy can be used to relieve upper airway obstruction as well as aid in ventilation. PAP therapy is effective in treatment of OSAS in children and adults, although with pediatric patients, additional considerations and limitations exist. Active management and care for various considerations important to pediatric patients with OSAS can allow PAP to be an effective and safe therapy in this population.


2021 ◽  
Vol 37 (1) ◽  
Author(s):  
Chinyere N. Asoegwu ◽  
Okezie O. Kanu ◽  
Clement C. Nwawolo

Abstract Background Primary malignant tumours of the retropharyngeal space are rare with only a few case reports in the literature. Lymphoplasmacytic lymphoma is a rare subtype of non-Hodgkin lymphoma and is very rarely found as a primary tumour of the retropharyngeal space. Case presentation We report the case of progressive upper airway obstruction in a 49-year-old male caused by a primary malignant tumour of the retropharyngeal space lymph nodes. He had an emergency tracheostomy to relieve the upper airway obstruction followed a week later by an elective surgical excision of the tumour via the trans-cervical route. A mixed population of lymphocytes, with a marked presence of Dutcher bodies, was noted on histopathology and positive CD20 on immunohistochemistry, confirming the lymphoplasmacytic lymphoma of the retropharyngeal space. The watchful waiting treatment method for the lymphoma was employed for him since he had no symptoms relating to lymphoma and no serum Waldenström’s macroglobulinemia. He has remained symptom-free 3 years post-surgery. Conclusion Primary malignant tumours involving the retropharyngeal space lymph nodes are very rare. They can rarely grow to a size huge enough to cause obstructive upper aerodigestive symptoms. Primary lymphoma of the retropharyngeal space should be considered in the diagnosis of the tumours involving the retropharyngeal space lymph nodes. Excisional biopsy is important to obtain tissue for histopathological diagnosis and the relief of upper aerodigestive tract obstruction when present.


2021 ◽  
Vol 26 (Supplement_1) ◽  
pp. e11-e12
Author(s):  
Rahul Verma ◽  
Cora Mocanu ◽  
Jenny Shi ◽  
Michael Miller ◽  
Jackie Chiang ◽  
...  

Abstract Primary Subject area Respirology Background Despite the large morbidity and potential mortality associated with tracheostomy tube decannulation failure, there are currently no consensus guidelines on pediatric tracheostomy decannulation. This has led to wide practice variation that is largely based on expert option. This is the largest review of pediatric decannulation protocols. Objectives To systematically review the literature on existing pediatric decannulation protocols, including the role of polysomnography, and their clinical outcomes. Design/Methods Five online databases were searched for relevant studies from database inception to May 29, 2020. Study inclusion was limited to publications that evaluated tracheostomy decannulation in children 18 years of age and younger. Independent reviewers extracted data, including patient demographics and primary indication for tracheostomy. Methods used to assess readiness for decannulation were noted, including the use of bronchoscopy, tracheostomy tube modifications, and gas exchange measurements. After decannulation, details regarding mode of ventilation, location and length of observation period, and clinical outcomes were also collected. Quality assessment of included studies was performed using the Newcastle-Ottawa Scale (NOS) tool. Descriptive statistical analyses were performed. Results Twenty-three studies with 1328 children were included (Figure 1). Tracheostomy indications included upper airway obstruction at a well-defined anatomic site (37%), upper airway obstruction not at a well-defined site (13%), and need for long-term ventilation (50%). Bronchoscopy was routinely used in 96% of protocols. Tracheostomy tube modifications in the protocols included capping (83%), downsizing (57%), and fenestrations (9%). Measurements of gas exchange in the protocols included polysomnography (72%), oximetry (61%), blood gases (17%), and capnography with end-tidal CO2 (17%). After tracheostomy decannulation, children in 92% of protocols were transitioned to room air, and 38% of protocols used non-invasive ventilation. Most children (76%) were observed in hospital for 48 hours or less. Of all decannulation attempts, 79% were successful. Overall risk of bias in included studies was low. Conclusion The absence of clear evidence-based guidelines in pediatric tracheostomy decannulation has led to large variability in clinical practice. Most protocols include bronchoscopy, tube modifications, gas exchange measurements, and brief hospital admission. Polysomnography plays an integral role in assessing the majority of children for tracheostomy removal. Evidence-based guidelines to standardize pediatric tracheostomy care remain an urgent priority.


2021 ◽  
Vol 41 (5) ◽  
pp. 436-442
Author(s):  
Paola Festa ◽  
Nicola Mansi ◽  
Alfonso Maria Varricchio ◽  
Fabio Savoia ◽  
Camilla Calì ◽  
...  

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A375
Author(s):  
Sugi Min ◽  
Claudia Sorin ◽  
Gerardo Carino

Author(s):  
A. Mirra ◽  
M. Arnold ◽  
D. Casoni ◽  
E. Gámez Maidanskaia ◽  
L.G. Garcia Casalta ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Hannes Prescher ◽  
Jill R. Froimson ◽  
Pranav N. Haravu ◽  
Russell R. Reid

Sign in / Sign up

Export Citation Format

Share Document